Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer

Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer is a phase 2, interventional study registered as NCT06596343 by Sir Run Run Shaw Hospital, with a registry enrolment figure of 80 participants, started 2024-10 and due to reach its primary completion in 2027-09-30. Interventions recorded: Adjuvant Chemotherapy Combined with Traditional Chinese Medicine (TCM) Supportive Therapy. Conditions listed: Locally Advanced Colorectal Cancer; Postoperative Adjuvant Therapy. Primary outcome: The incidence of grade III/IV adverse events. Colorectal eligibility wording from the registry: "Diagnosed with colorectal cancer at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, and underwent standard radical colorectal cancer surgery". Sites: China. No results are recorded here; the registry entry is the source.